An infant in Wisconsin has died of measles, the first measles death in the state since 1990, officials reported Thursday. The death comes amid an outbreak in the Badger State that has stricken over 430 people across 13 counties this year.

"Any death of a child is a tragedy, and even more so when it is related to a vaccine-preventable disease," Wisconsin Health Secretary Kirsten Johnson said in a statement. "Measles can cause serious illness and death, and it is important for all Wisconsinites to evaluate their risk and take steps to protect themselves and their family."

The baby's death is the third measles fatality nationally just this week, following the death of a New York child reported on Monday and another death in Pennsylvania reported on Wednesday. The Pennsylvania death was of an unvaccinated person in Jefferson County; the state health department did not provide additional details, such as the age of the person. The state's explosive, ongoing measles outbreak has led to 1,467 cases so far this year.

Read full article

Comments

As Democrats blew away their Republican rivals in an unprecedented midterm sweep Tuesday, the Make America Health Again movement also got bowled over, raising questions about the fate of the motley movement.

MAHA—which has centered around anti-vaccine activist and current Health Secretary Robert F. Kennedy Jr.—saw many of its favored candidates and allies lose, while vocal adversaries of Kennedy won. And the coalition was splintering under stress even before the voting started; in recent months, supporters have accused Kennedy and the Trump administration of inaction and betrayals in their two years in power.

Now hobbled in Washington, shedding supporters, and showing little to no influence in voting booths, is MAHA on its deathbed? Or will it be reborn—possibly into a new group? Could it be assimilated into a blue platform—after sloughing off the more repulsive, conspiratorial aspects of Kennedy's ideology? These are the questions circling in the aftermath of Tuesday's bloodbath.

Read full article

Comments

Calley Means—a top ally to anti-vaccine Health Secretary Robert F. Kennedy Jr. and a co-author of the so-called "MAHA bible"—resigned from his role in the Trump administration Thursday, reportedly in frustration over delays to food policy changes sought by the Make America Healthy Again movement.

"I am resigning from the White House with tremendous respect for President Trump and Bobby Kennedy," Means wrote in a social media post this afternoon. "It was an honor to advocate for MAHA moms in the administration and steer policies like Dietary Guidelines reform, psychedelic reform, removing soda from SNAP, removing food dyes, GRAS reform, and overhauling government food procurement."

His post did not provide a reason for his departure. Means served as a senior advisor to Kennedy.

Read full article

Comments

Government officials in Guinea-Bissau have formally rejected a clinical trial that would be run by Danish researchers and funded by the US to look for alleged nonspecific harms from the newborn dose of the hepatitis B vaccine. The vaccine dose is currently recommended globally for all newborns and has been used safely and effectively for decades.

In an email to Ars Technica, one of the trial's lead researchers, Christine Stabell Benn of Bandim Health Project and the University of Southern Denmark, said that Guinea-Bissau's Council of Ministers "formally reaffirmed its non-acceptance of the study on 16 October."

The revelation that the study was formally rejected last week comes after news on Monday that judicial police in Guinea-Bissau raided Bandim Health's offices and seized vaccines. Stabell Benn highlighted that the police search came after the trial was rejected.

Read full article

Comments

Police in Guinea-Bissau raided the offices of Danish researchers on Monday, seizing doses of hepatitis B vaccine intended for a vaccine trial for newborns. International health experts have called the trial "unethical," but anti-vaccine Health Secretary Robert F. Kennedy Jr. has attempted to fund it with US taxpayer dollars.

Under Kennedy, the US Centers for Disease Control and Prevention announced in December that it had awarded the Danish researchers—led by married couple Peter Aaby and Christine Stabell Benn of Bandim Health Project—an unsolicited $1.6 million grant to run the trial. Aaby and Stabell Benn are controversial vaccine researchers who claim vaccines cause overlooked harms. They have been repeatedly praised by Kennedy but are currently under investigation by Danish authorities for alleged scientific misconduct.

Plans for the trial were halted in January as widespread condemnation erupted over the trial's design, which would potentially expose thousands of newborns in the country to hepatitis B, risking a lifelong infection that can lead to liver cirrhosis, cancer, and premature death. Outrage flared again after a Rolling Stone story earlier this month claimed the CDC set aside another $1.6 million in funding in late September and planned to move forward with the trial.

Read full article

Comments

Under Health Secretary Robert F. Kennedy Jr., the Food and Drug Administration is moving forward with plans to ease access to unproven peptide drugs that are popular among members of Kennedy's Make America Healthy Again movement—despite FDA staff scientists finding that the drugs have not been sufficiently studied to establish safety and efficacy and may cause harms.

The FDA submitted an "Interim Access Policy" on peptides for review by the White House, according to a filing notice posted on an Office of Management and Budget website. The posting does not provide information on the proposed policy. But people familiar with the proposal told The Associated Press that it would give the FDA "enforcement discretion" on certain peptide drugs. This would allow the agency to choose not to enforce current restrictions on peptides and provide an assurance to specialty pharmacies eager to start making them that they will not be targeted by the agency.

The Department of Health and Human Services, which oversees the FDA, did not respond to a request for comment from Ars Technica.

Read full article

Comments